Search Results 341-350 of 11317 for sildenafil

  1. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  2. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  3. Gastroenterology and Hepatology - Clinical trials

    This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

  4. Cardiovascular Medicine - Clinical trials

    The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...

  5. Drugs and Supplements that Start with D - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...

  6. Idelalisib (oral route) - Side effects & dosage - Mayo Clinic

    Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes ...

  7. Drugs and Supplements that Start with O - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “O” to learn about drug side effects, proper use and ...

  8. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  9. Leniolisib (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  10. Ensartinib (oral route) - Side effects & dosage - Mayo Clinic

    Ensartinib is used to treat non-small cell lung cancer (NSCLC) that has spread in patients who have not received other medicines (eg, ALK-inhibitors) and whose ...